The Federal Reserve indicated that more upbeat economic data was needed before raising interest rates. The markets closed higher with the Dow climbing 74 points to 21,012. Nasdaq gained 24 points to 6,163.
On the upside
Triumph Group (NYSE: TGI) narrowed losses for the fourth quarter.
The Food and Drug Administration's Oncologic Drugs Advisory Committee recommended approval of Puma Biotechnology's (Nasdaq: PBYI) breast cancer treatment neratinib.
Tilly's (NYSE: TLYS) narrowed first quarter losses more than expected.
On the downside
Bristow Group (NYSE: BRS) widened losses for the fourth quarter.
Neurocrine Biosciences (Nasdaq: NBIS) reported disappointing results from a Phase II Tourette syndrome T-Force Green study of Ingrezza.
Tiffany (NYSE: TIF) reported an unexpected drop in same store sales.
The broader S&P 500 added a point to 2,399. Bitcoin leaped $240 to $2466.